Your well-beingARIMIDEX refill reminder

Taking your medication according to your doctor's orders may help reduce the risk of breast cancer recurring. So it's important to take your medication as prescribed by your doctor. But remembering to take your medication can be a challenge. This refill reminder is one way to help you avoid running out of your medication.


Sign up for an ARIMIDEX refill reminder

Need a reminder to refill your prescription? Simply fill out the form below and we'll send you an e-mail reminder before your next prescription needs to be filled.

  1. * Required
  3.  
  4.  
  5.    
  6. * Date of Last Prescription:
  7.      
  8. * Please Specify Your Prescription Length:
  9.  days  
  1. Yes, I would also like to receive information in the future about ARIMIDEX and related health information.
  2. Yes, I would also like to receive information in the future about all AstraZeneca products, programs, and services that may be of interest to me.
  3. Yes, I would be willing to be contacted on occasion to participate in market research studies sponsored by AstraZeneca.

If in the future you no longer want to receive this information, please call 1-800-236-9933.


To view the download, you need Adobe® Acrobat® Reader® installed. If you do not have Adobe Acrobat Reader on your computer, you can download it from the Adobe Web site.

Adobe Acrobat Reader is a registered trademark of Adobe Systems Incorporated.

Important Information About ARIMIDEX

ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.

ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX.

Important Safety Information About ARIMIDEX

  • Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child
  • Based on information from a study in patients with early breast cancer, women with a history of blockages in heart arteries (ischemic heart disease) who take ARIMIDEX may have a slight increase in this type of heart disease compared to similar patients who take tamoxifen
  • ARIMIDEX can cause bone softening/weakening (osteoporosis) increasing the chance of fractures. In a clinical study in early breast cancer, there were more fractures (including fractures of the spine, hip, and wrist) with ARIMIDEX (10%) than with tamoxifen (7%)
  • In a clinical study in early breast cancer, some patients taking ARIMIDEX had an increase in cholesterol. Skin reactions, allergic reactions, and changes in blood tests of liver function have also been reported
  • In the early breast cancer clinical trial, the most common side effects seen with ARIMIDEX include hot flashes, joint symptoms (including arthritis and arthralgia), weakness, mood changes, pain, back pain, sore throat, nausea and vomiting, rash, depression, high blood pressure, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache
  • In advanced breast cancer trials, the most common side effects seen with ARIMIDEX versus tamoxifen include hot flashes, nausea, decreased energy and weakness, pain, back pain, headache, bone pain, increased cough, shortness of breath, sore throat, and swelling of arms and legs. Joint pain/stiffness has been reported in association with the use of ARIMIDEX
  • ARIMIDEX should not be taken with tamoxifen or estrogen-containing therapies

Please click here for full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088 (1-800-332-1088).